Discover the full record of transactions filed by Horning Sandra, Director. Officer active across 3 companies, notably EQRx, Inc.. Aggregated, 4 disclosures have been published. The latest transaction was filed on 28 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Sandra Horning is a Director at EQRx, Inc., Moderna, Inc., and Gilead Sciences, Inc. She brings extensive experience in the biotechnology and healthcare sectors, having held various leadership positions within leading organizations. Her expertise in business strategy and product development is essential for guiding the boards in their decisions. Sandra is also involved in initiatives aimed at improving healthcare access.